OGS vs REGN
One Gas Inc (OGS) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
One Gas Inc (OGS) is a utilities - regulated gas company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported OGS revenue for 2022-12-31 was $2.58B. Net income was $221.7M. OGS currently screens at market cap $4.85B and trailing P/E 17.4.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
OGS currently screens at market cap $4.85B and trailing P/E 17.4. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the OGS and REGN stock pages for the full models.
Not investment advice.